Release Date: 14/02/12 10:52 Summary: Ceasing to be a substantial holder Price Sensitive: No Download Document 173.85KB Download
MSB Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%